{"doi":"10.1016\/j.jchromb.2006.10.059","coreId":"135789","oai":"oai:bradscholars.brad.ac.uk:10454\/3775","identifiers":["oai:bradscholars.brad.ac.uk:10454\/3775","10.1016\/j.jchromb.2006.10.059"],"title":"Validation of high-performance liquid chromatography assay for quantification of formoterol in urine samples after inhalation using UV detection technique.","authors":["Nadarassan, D.K.","Chrystyn, H.","Clark, Brian J.","Assi, Khaled H."],"enrichments":{"references":[],"documentType":{"type":null}},"contributors":[],"datePublished":"2007","abstract":"NoA novel high-performance liquid chromatography (HPLC) assay for the estimation of formoterol in urine samples was developed and validated. A solid phase extraction (SPE) using Oasis HLB was optimised to isolate formoterol from a urine matrix followed by HPLC with UV detection. This extraction procedure concentrated the final analyte forty times so that UV detection can be used to determine even a low concentration of formoterol in urine samples. The urinary assay was performed in accordance with FDA and ICH regulations for the validation of bioanalytical samples. The samples were injected onto a C18 Spherisorb\u00ae (250 mm x 4.6 mm x 5 \u00bfm) analytical column maintained at 30 \u00b0C. The mobile phase consisted of 5 mM of potassium dihydrogen orthophosphate buffer (adjusted to pH 3 with ortho phosphoric acid):acetonitrile (ACN) (70:30, v\/v), and the formoterol peak was detected at wavelength 214 nm. The extraction recovery of formoterol from the urine sample was >95%. The calibration curve was linear (r2=0.99) over formoterol concentrations ranging from 1.5 to 25 ng\/mL (n=6). The method had an accuracy of >92% and intra and inter-day precision CV% of <3.9% and <2.2%, respectively, at three different concentrations low, medium and high (10, 15, 20 ng\/mL). The limit of quantification (LOQ) for formoterol was found to be 1.50 ng\/mL. The accuracy and precision at the LOQ level were 95% and %CV <3.7% (n = 10), respectively. The method reported is simple, reliable, precise, and accurate and has the capacity to be used for determination of formoterol in urine samples","downloadUrl":"","fullTextIdentifier":null,"pdfHashValue":null,"publisher":null,"rawRecordXml":"<record><header><identifier>\n        \n            \n                oai:bradscholars.brad.ac.uk:10454\/3775<\/identifier><datestamp>\n                2016-08-18T17:11:29Z<\/datestamp><setSpec>\n                com_10454_152<\/setSpec><setSpec>\n                col_10454_6342<\/setSpec>\n            <\/header><metadata><oai_dc:dc xmlns:oai_dc=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/\" xmlns:dc=\"http:\/\/purl.org\/dc\/elements\/1.1\/\" xmlns:doc=\"http:\/\/www.lyncode.com\/xoai\" xmlns:xsi=\"http:\/\/www.w3.org\/2001\/XMLSchema-instance\" xsi:schemaLocation=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/ http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc.xsd\" ><dc:title>\n            \nValidation of high-performance liquid chromatography assay for quantification of formoterol in urine samples after inhalation using UV detection technique.<\/dc:title><dc:creator>\nNadarassan, D.K.<\/dc:creator><dc:creator>\nChrystyn, H.<\/dc:creator><dc:creator>\nClark, Brian J.<\/dc:creator><dc:creator>\nAssi, Khaled H.<\/dc:creator><dc:subject>\n\u00df-Adrenergic receptor agonist<\/dc:subject><dc:subject>\n\u00df2-Adrenergic receptor<\/dc:subject><dc:subject>\nAgonist<\/dc:subject><dc:subject>\nBronchodilator<\/dc:subject><dc:subject>\nAntiasthma agent<\/dc:subject><dc:subject>\nUltraviolet detector<\/dc:subject><dc:subject>\nInhalation<\/dc:subject><dc:subject>\nUrine<\/dc:subject><dc:subject>\nFormoterol<\/dc:subject><dc:subject>\nQuantitative analysis<\/dc:subject><dc:subject>\nHPLC chromatography<\/dc:subject><dc:subject>\nValidation<\/dc:subject><dc:description>\nNo<\/dc:description><dc:description>\nA novel high-performance liquid chromatography (HPLC) assay for the estimation of formoterol in urine samples was developed and validated. A solid phase extraction (SPE) using Oasis HLB was optimised to isolate formoterol from a urine matrix followed by HPLC with UV detection. This extraction procedure concentrated the final analyte forty times so that UV detection can be used to determine even a low concentration of formoterol in urine samples. The urinary assay was performed in accordance with FDA and ICH regulations for the validation of bioanalytical samples. The samples were injected onto a C18 Spherisorb\u00ae (250 mm x 4.6 mm x 5 \u00bfm) analytical column maintained at 30 \u00b0C. The mobile phase consisted of 5 mM of potassium dihydrogen orthophosphate buffer (adjusted to pH 3 with ortho phosphoric acid):acetonitrile (ACN) (70:30, v\/v), and the formoterol peak was detected at wavelength 214 nm. The extraction recovery of formoterol from the urine sample was >95%. The calibration curve was linear (r2=0.99) over formoterol concentrations ranging from 1.5 to 25 ng\/mL (n=6). The method had an accuracy of >92% and intra and inter-day precision CV% of <3.9% and <2.2%, respectively, at three different concentrations low, medium and high (10, 15, 20 ng\/mL). The limit of quantification (LOQ) for formoterol was found to be 1.50 ng\/mL. The accuracy and precision at the LOQ level were 95% and %CV <3.7% (n = 10), respectively. The method reported is simple, reliable, precise, and accurate and has the capacity to be used for determination of formoterol in urine samples.<\/dc:description><dc:date>\n2009-10-27T14:47:28Z<\/dc:date><dc:date>\n2009-10-27T14:47:28Z<\/dc:date><dc:date>\n2007<\/dc:date><dc:type>\nArticle<\/dc:type><dc:type>\nNo full-text available in the repository<\/dc:type><dc:identifier>\nNadarassan, D.K., Chrystyn, H., Clark, B.J. and Assi, K.H. (2007). Validation of high-performance liquid chromatography assay for quantification of formoterol in urine samples after inhalation using UV detection technique.  Journal of Chromatography: B. Vol. 850, No. 1-2, pp. 31-37.<\/dc:identifier><dc:identifier>\n90006689<\/dc:identifier><dc:identifier>\n90009314<\/dc:identifier><dc:identifier>\nhttp:\/\/hdl.handle.net\/10454\/3775<\/dc:identifier><dc:language>\nen<\/dc:language><dc:relation>\nhttp:\/\/dx.doi.org\/10.1016\/j.jchromb.2006.10.059<\/dc:relation>\n<\/oai_dc:dc>\n<\/metadata>\n        <\/record>","journals":null,"language":null,"relations":["http:\/\/dx.doi.org\/10.1016\/j.jchromb.2006.10.059"],"year":2007,"topics":["\u00df-Adrenergic receptor agonist","\u00df2-Adrenergic receptor","Agonist","Bronchodilator","Antiasthma agent","Ultraviolet detector","Inhalation","Urine","Formoterol","Quantitative analysis","HPLC chromatography","Validation"],"subject":["Article","No full-text available in the repository"],"fullText":null}